Correlation between Lipid Profile and Kidney Function in Ambulatory Heart Failure Patient

Authors

  • Sidhi Laksono Purwowiyoto Departement of Cardiology and Vascular, Pertamina Central Hospital, South Jakarta, Jakarta Departement of Cardiology and Vascular, Faculty of Medicine, Universitas Muhammadiyah Prof. Dr. Hamka, Tangerang
  • Hengkie Frankie Lasanudin Departement of Cardiology and Vascular, Pertamina Central Hospital, South Jakarta, Jakarta
  • Budhi Setianto Departement of Cardiology and Vascular, Faculty of Medicine, Universitas Indonesia, Depok, West Java
  • Steven Philip Surya Primaya Hospital, Tangerang, Banten
  • Wincent Candra Diwirya Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Central Java

DOI:

https://doi.org/10.18196/mmjkk.v1i1.9969

Keywords:

Lipid Profile, Heart Failure, Cardiorenal

Abstract

Heart failure contributes to a high number of hospitalizations. Currently, the number of outpatients is more dominant than hospitalized heart failure patients. Unfortunately, a study in the outpatient setting is still limited. This study aims to evaluate the correlation between lipid profile and kidney function in ambulatory heart failure patients. This study is a single-center cross-sectional study. Data were collected from August to September 2020. Data were extracted from 62 medical records of heart failure patients with ejection fraction <45%. Exclusion criteria were life-threatening comorbidity and patient with routine hemodialysis. Data were analyzed with Pearson or Spearman correlation test. Most of the heart failure patients in our outpatient clinic are elderly (>60 years old) and male (58%). The researchers found positive correlation of total cholesterol (r 0.39; p 0.001) and triglyceride (r 0.59; p 0.001) to serum creatinine. On the other hand, LDL and blood cholesterol ratio negatively correlated with serum creatinine, r - 0.31; p 0.016; and r - 0.46; p 0.001; respectively. All of this analysis was statistically significant. It concluded that lipid profiles were correlated with kidney function in heart failure patients

Author Biography

Sidhi Laksono Purwowiyoto, Departement of Cardiology and Vascular, Pertamina Central Hospital, South Jakarta, Jakarta Departement of Cardiology and Vascular, Faculty of Medicine, Universitas Muhammadiyah Prof. Dr. Hamka, Tangerang

Head of cathlab RSUD Pasar Rebo, Department of cardiology and vascular medicine

References

Kurmani S, Squire I. Acute Heart Failure: Definition, Classification and Epidemiology. Curr Heart Fail Rep 2017; 14(5): 385–392. https://doi.org/10.1007/s11897-017-0351-y

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37(27): 2129–2200. https://doi.org/10.1093/eurheartj/ehw128

Rajadurai J, Tse H-F, Wang C-H, Yang N-I, Zhou J, Sim D. Understanding the Epidemiology of Heart Failure to Improve Management Practices: An Asia-Pacific Perspective. J Card Fail 2017; 23(4): 327–339. https://doi.org/10.1016/j.cardfail.2017.01.004

Siswanto BB, Radi B, Kalim H, Santoso A, Suryawan R, Erwinanto et al. Heart Failure in NCVC Jakarta and 5 hospitals in Indonesia. CVD Prevention and Control 2010; 5(1): 35–38. https://doi.org/10.1016/j.cvdpc.2010.03.005

Ishigami J, Cowan LT, Demmer RT, Grams ME, Lutsey PL, Carrero J-J et al. Incident Hospitalization with Major Cardiovascular Diseases and Subsequent Risk of ESKD: Implications for Cardiorenal Syndrome. J Am Soc Nephrol 2020; 31(2): 405–414. https://doi.org/10.1681/ASN.2019060574

Sarnak MJ. A Patient with Heart Failure and Worsening Kidney Function. Clin J Am Soc Nephrol 2014; 9(10): 1790–1798. https://doi.org/10.2215/CJN.11601113

Löfman I, Szummer K, Hagerman I, Dahlström U, Lund LH, Jernberg T. Prevalence and prognostic impact of kidney disease on heart failure patients. Open Heart 2016; 3: e000324. https://doi.org/10.1136/openhrt-2015-000324

Zhang H, Shi S, Zhao X-J, Wang J-K, Liu Z-W, Liu F-Q et al. Association Between the Lipid Profile and Renal Dysfunction in the Heart Failure Patients. Kidney Blood Press Res 2019; 44: 52–61. https://doi.org/10.1159/000498834

Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP et al. Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol 2007; 18(4): 1307–1315. https://doi.org/10.1681/ASN.2006101159

Damman K, Testani JM. The kidney in heart failure: an update. European Heart Journal 2015; 36(23): 1437–1444. https://doi.org/10.1093/eurheartj/ehv010

Gnanaraj J, Radhakrishnan J. Cardio-renal syndrome. F1000Res 2016; 5: F1000 Faculty Rev-2123.

Li H, Hastings MH, Rhee J, Trager LE, Roh JD, Rosenzweig A. Targeting Age-Related Pathways in Heart Failure. Circ Res 2020; 126: 533–551. https://doi.org/10.1161/CIRCRESAHA.119.315889

Paneni F, Diaz Cañestro C, Libby P, Lüscher TF, Camici GG. The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels. Journal of the American College of Cardiology 2017; 69(15): 1952–1967. https://doi.org/10.1016/j.jacc.2017.01.064

Jakovljevic DG. Physical activity and cardiovascular aging: Physiological and molecular insights. Exp Gerontol 2018; 109: 67–74. https://doi.org/10.1016/j.exger.2017.05.016

Romiti GF, Recchia F, Zito A, Visioli G, Basili S, Raparelli V. Sex and Gender-Related Issues in Heart Failure. Heart Fail Clin 2020; 16: 121–130. https://doi.org/10.1016/j.hfc.2019.08.005

Duru OK, Vargas RB, Kermah D, Nissenson AR, Norris KC. High Prevalence of Stage 3 Chronic Kidney Disease in Older Adults Despite Normal Serum Creatinine. J Gen Intern Med 2009; 24: 86–92. https://doi.org/10.1007/s11606-008-0850-3

Baumgarten M, Gehr T. Chronic kidney disease: detection and evaluation. Am Fam Physician 2011; 84: 1138–1148.

Lanktree MB, Thériault S, Walsh M, Paré G. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study. Am J Kidney Dis 2018; 71(2): 166–172. https://doi.org/10.1053/j.ajkd.2017.06.011

Reiss AB, Voloshyna I, De Leon J, Miyawaki N, Mattana J. Cholesterol Metabolism in CKD. Am J Kidney Dis 2015; 66(6): 1071–1082. https://doi.org/10.1053/j.ajkd.2015.06.028

Afshinnia F, Pennathur S. Lipids and Cardiovascular Risk with CKD. Clin J Am Soc Nephrol 2020; 15(1): 5–7. https://doi.org/10.2215/CJN.13531119

Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C et al. Cholesterol and the Risk of Renal Dysfunction in Apparently Healthy Men. JASN 2003; 14(8): 2084–2091. https://doi.org/10.1681/ASN.V1482084

Downloads

Additional Files

Published

2021-12-31

Issue

Vol. 22 No. 1 (2022): January

Section

Research

License

Copyright

Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).

Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).

License

Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:

  • Share — copy and redistribute the material in any medium or format.
  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:

  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.